Zepbound (tirzepatide) - Eli Lilly
Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide (clinicaltrials.gov) - Oct 22, 2026 - P4 | N=150 | Recruiting | Sponsor: Technical University of Munich | Trial completion date: May 2027 ➔ Aug 2027 | Trial primary completion date: May 2027 ➔ Aug 2027 
Trial completion date • Trial primary completion date • Genetic Disorders • Obesity
http://clinicaltrials.gov/ct2/show/NCT07777575
 
Oct 22, 2026
 
Prev Next